1. Sun Pharmaceutical Industries Ltd.
With more than 40 manufacturing facilities, Sun Pharmaceutical is the largest international pharmaceutical company in India. Sun Pharma was founded by Dilip Sanghavi. Mumbai, Maharashtra, the financial centre of India, is home to the company’s headquarters. Sun Pharma’s formulations and active pharmaceutical ingredients (APIs) are well-known. Chronic and acute therapies are the main focus.
In the fields of anti-infectives, neurology, cardiology, orthopaedics, diabetology, gastric medications, medical specialties, nephrology, urology, skin-related, gynecology, respiratory, cancer, dental, and nutrition, it contains over 3000 high-quality molecules. With a market value of Rs. 1,68,768.88 cr., Sun Pharma continued to be the top pharmaceutical company in India in June 2019.
Around 2000 research professionals are employed by Sun Pharma across several R&D facilities. By working with T.R.A. Research and BlueBytes, a prestigious media analytics company, Sun Pharma was placed second on the list of India’s Most Reputable Brands (Pharma).
A few of the Awards given to it are:
It won the Golden Peacock Award for Corporate Social Responsibility in 2020.
In Pharmaceuticals Sectoral Performance-based Category sun pharma won the Dun & Bradstreet India Corporate Award.
‘Best New Product Introduction/Promotion’ winner of the DIANA (Distribution Industry Award for Notable Achievements in Healthcare) award at the 2021 Annual Healthcare Distribution Alliance Conference.
Named as the Best Innovative Company of the Year 2021 by the Indo-American Corporate Excellence Awards.
2. Divis Labs
The business holds certifications for OHSAS-18001, ISO-9001 (Quality System), and ISO-14001 (Environmental Management Systems). Divis was established more than 29 years ago in Hyderabad. It provides generic APIs. The income for Divi’s public limited, a listed business, year 2020–21 is estimated to be Rs 1,741 crore. The development and research teams at Divis Lab are working hard to provide a non-infringing procedure.
Manufacturing: Currently runs two facilities that meet the requirements of a number of regulatory agencies, including the USFDA, ANVISA, E.U. cGMP, Health Canada, PMDA, TGA, and MFDS.
3. Dr Reddy’s Laboratories
The company’s founder, Kallam Anji Reddy, was born in Tadepalli, Andhra Pradesh. His father was a farmer, and he grew up on a farm. He observed his father making herbal medications and giving them away. Kallam Anji Reddy spent six years with IDPL Pharma before departing in 1973. Kallam Anji reddy participated in two production units for the following 10 years. He made the decision to launch Dr. Reddy’s Laboratories in 1984.
It quickly started exporting to other less-regulated markets after beginning as a supplier and transitioning to an Indian drug manufacturer. These markets benefited from not having to spend time and money building a manufacturing facility that would receive approval from a drug licencing body like the United States Food and Drug Administration (F.D.A.).
The company’s expanding size and profitability from these uncontrolled markets at the beginning of the 1990s assisted in obtaining a drug regulator accreditation for its formulations and medication manufacturing facilities – in more developed nations. They were able to access regulated markets like those in the US and Europe as a result.
4. Lupin Ltd.
The founder of Lupin is Dr. Desh Bandhu Gupta, who also served as its former chairman. Lupin has its headquarters in Mumbai. World-class production facilities for Lupin are situated in Brazil, Mexico, India, Japan, and the United States.
The full pharmaceutical product cycle is covered by Lupin’s research programme. The research park of Lupin has approximately 1,400 scientists working there and is close to Aurangabad and Pune, is the focal point of the company’s R&D programme. Pharmaceutical Research Advanced Drug Delivery Systems (ADDS) Research Intellectual Property Management, Novel Drug Discovery and Development (NDDD) Biotechnology Research are the Lupin’s R & D units.
The co-founder of Cipla is Khwaja Abdul Hamied. Cipla is a well-known company that produces high-quality products across all branded and generic medicines. Over the past few decades, we have solidified our position as the market leader in India’s pharmaceutical sector. Cipla Limited is a multinational pharmaceutical company with headquarters in Mumbai, India.
Its market capitalization as of September 17, 2014, was 49,611,58 crore (560 billion, or $7.5 billion in 2020), ranking it as the 42nd largest publicly traded company in India. Cipla provides pharmaceutical and personal care goods, including escitalopram oxalate (an antidepressant), lamivudine, and fluticasone propionate, to other producers. They are the top manufacturer of antiretroviral drugs in the entire world.
The company launched Gilead Sciences’ remdesivir under the trade name CIPREMI in India in July 2020 following the conclusion of a voluntary licensure agreement with the parent company and DCGI clearance for “limited emergency use” in COVID-19 treatment of critically confirmed patients.
6. Aurobindo Pharma Ltd.
With the semi-synthetic antibiotic drug penicillin, Mr. P. V. Ramprasad Reddy and Mr. K. Nityananda Reddy established the Aurobindo Pharmaceutical Company in Pondicherry in 1986. It currently has the largest R&D facilities.
Aurobindo Pharma Limited is a pharmaceutical manufacturing company with headquarters in Hyderabad, India’s HITEC City. The company creates active pharmaceutical components and generic pharmaceuticals. The company’s six main therapeutic/product categories are: antibiotics, antiretrovirals, cardiovascular drugs, central nervous system goods, gastroenterological, and anti-allergic. The company offers these products in more than 125 nations.
7. Cadila, Zydus
A multinational pharmaceutical company with headquarters in Ahmedabad, Gujarat, India, Cadila Healthcare Limited (Zydus Cadila) mostly produces generic medications. It came in at number 100 on the Fortune India 500 list in 2020. By 2020, Raman Bhai Patel’s Zydus Cadila, which is present in more than 25 countries and has more than 30 production facilities in India, the United States, and Brazil, will be ranked seventh in India.
Twenty-five pharmaceutical production facilities in India are used by Zydus Cadila to research and develop pharmaceuticals, diagnostics, herbal products, skincare products, and other OTC items. Ankleshwar, Vadodara, and Patalganga are the Indian cities where the company produces active pharmaceutical components.
8. Piramal Healthcare Enterprises, Inc.
Parimal Healthcare is one of the top 10 pharmaceutical companies in India. It has operations in 30 countries and about 15,000 employees worldwide. The company is run by Mr. Ajay Piramal. A worldwide corporation with interests in real estate, financial services, and medicines is called Piramal Group. The Group has operations in more than 30 countries and a presence in more than 100 markets worldwide.
The Piramal Group, under the leadership of its chairman, Mr. Ajay Piramal, is a pioneer for sustainability and an ethical corporate approach. By adhering to the principle of “Doing Well and Doing Good,” the Group continues to generate long-term value for its stakeholders and the community.
The Piramal Foundation supports social programmes that focus on one of three main areas: Primary Healthcare and Nutrition are provided by Piramal Swasthya Education Leadership is taught at the Piramal School of Leadership, and Piramal Sarvajal: Access to Safe Drinking Water.
The company Glenmark was founded by Gracias Saldanha. One of his two sons, Glenn Saldanha, serves as Glenmark’s current chief executive. The CEO of Markson’s, a pharmaceutical company with 17 manufacturing sites and 5 R&D centres devoted to enhancing people’s lives, is Mark Saldanha.
An Indian pharmaceutical company with its headquarters in Mumbai is called Glenmark Pharmaceuticals Limited. It was established in 1977 as a producer of active pharmaceutical ingredients and generic medications by Gracias Saldanha, who gave the business their names.
The company established its first research centre and went public in India in 1999. After returning to India from a period at PricewaterhouseCoopers, Glenn Saldanha, Saldanha’s son, was named CEO in 2001. By 2008, Glenmark ranked as India’s fifth-largest pharmaceutical company.
After research indicated that the medicine showed some potential for treating COVID-19, the company began marketing the potential COVID-19 drug Favipiravir under the trade name FabiFlu in India in June 2020. A more capable version of FabiFlu will be released in August 2020.
10. Torrent Pharmaceuticals Ltd.
Torrent Pharma, which employs more than 8800 people and conducts business in more than 50 countries, was founded by Sudhir and Samir Mehta. The Torrent Group owns and controls Torrent Pharmaceuticals Ltd, an international pharmaceutical company with its headquarters in Ahmedabad. Torrent Pharmaceuticals Ltd. eventually replaced the moniker Trinity Laboratories Ltd. that U. N. Mehta had used to promote the company.
Torrent Pharmaceuticals has operations in more than 40 nations and has more than 2000 registered products worldwide. Therapeutic categories covered by Torrent Pharma include those for the cardiovascular (CV), central nervous system (C.N.S. ), gastro-intestinal, diabetology, anti-infective, and pain management. While concentrating on gynaecology and paediatrics, it has expanded into nephrology and cancer therapy. Other well-known pharmaceutical companies are also operated by the Indian government; they are all owned by it.
The largest Central Pharma Public Sector Undertaking in India is Indian Drugs and Pharmaceuticals Ltd. (IDPL), which has facilities in Rishikesh, Gurgaon, and Hyderabad as well as two subsidiary operations in Chennai and Muzaffarpur.
IDPL contributes significantly to essential National Health Programs including Family Welfare Program and Population Control (Mala-D and Mala-N), Antimalarials (Chloroquine), and Prevention of Dehydration by providing high-quality medications (O.R.S.). In 1994, when the nation experienced the tragedy of a plague outbreak, IDPL was the only business that was instrumental in getting Tetracycline to people in need. Similarly to this, the company has made sure there is a supply of chloroquine to combat the pandemic of malaria.